Boehringer Ingelheim Biopharmaceuticals (China) Ltd.
FDA-inspected organization
Boehringer Ingelheim Biopharmaceuticals (China) Ltd. has been audited by the FDA 1 times between 2023 and 2023 across all 1 sites.
Documents

FDA 483 Boehringer Ingelheim Biopharmaceuticals (China) Ltd., Shanghai | 2023
Out of stock
